PRU:NYSEPrudential Financial, Inc. Analysis
Data as of 2026-05-19 - not real-time
$101.51
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Prudential Financial is trading at $101.51, comfortably above its 20‑day (≈$99.15) and 50‑day (≈$97.35) SMAs but still below the 200‑day SMA (≈$104.34), signaling a short‑term bullish bias within a longer‑term neutral framework. The MACD histogram is positive (≈0.29) and the MACD line sits above its signal, reinforcing the near‑term upside momentum, while the RSI at 56 % suggests the stock is not overbought. Valuation metrics are attractive: the trailing P/E of ~10.5 is well under the industry average of 16.5, and the price‑to‑book ratio of ~1.09 hovers near book value, indicating the market may be undervaluing the balance sheet. A dividend yield of 5.44 % with a payout ratio of 56 % is supported by robust free cash flow of $10.4 B, pointing to dividend sustainability. However, the company carries a high debt‑to‑equity ratio of ~159, and recent analyst downgrades from Morgan Stanley and Barclays to underweight reflect concerns over leverage and earnings stability. Volume trends are decreasing and 30‑day volatility is elevated at ~25 %, adding short‑term price uncertainty. The Fear & Greed Index reads “Extreme Greed,” suggesting market optimism may be overstated. Overall, the stock appears fairly valued with modest upside potential (~1 % downside per the DCF model) and a strong income component, but investors should weigh the leverage and recent negative sentiment.
Given these dynamics, a cautious stance is warranted: hold the position to capture the dividend while monitoring the leverage profile and any further rating changes, with a view to adjust if the price breaches the $104 resistance or falls toward the $92 support.
Given these dynamics, a cautious stance is warranted: hold the position to capture the dividend while monitoring the leverage profile and any further rating changes, with a view to adjust if the price breaches the $104 resistance or falls toward the $92 support.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD and price above short‑term SMAs
- Recent analyst downgrades and decreasing volume
- High dividend yield with sustainable payout
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Valuation metrics (low P/E, near‑book P/B) suggest value appeal
- Strong free cash flow supporting dividend continuity
- Elevated leverage requiring monitoring
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Attractive dividend yield and payout ratio
- Undervalued relative to industry peers
- Stable earnings from diversified insurance and investment segments
Key Metrics & Analysis
Financial Health
Revenue Growth15.30%
Profit Margin5.48%
P/E Ratio10.5
ROE10.71%
ROA0.41%
Debt/Equity158.97
P/B Ratio1.1
Op. Cash Flow$9.8B
Free Cash Flow$10.4B
Industry P/E16.5
Technical Analysis
TrendNeutral
RSI56.2
Support$92.66
Resistance$104.11
MA 20$99.15
MA 50$97.35
MA 200$104.34
MACDBullish
VolumeDecreasing
Fear & Greed Index89.3
Valuation
Fair Value$682.89
Target Price$100.47
Upside/Downside-1.03%
GradeFair
TypeValue
Dividend Yield5.44%
Risk Assessment
Beta0.96
Volatility25.46%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.